Psoriasis, biologic therapy, and the pandemic of the 21st century
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.16/2586 |
Resumo: | The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood. The impact of COVID-19 on patients with psoriasis under biologic agents is continuously being observed in this rapidly changing pandemic. A case-by-case evaluation must be made by dermatologists, and the final decision should be discussed and decided by both the patient and the specialist. Observations reveal that immunosuppressive therapy may have a role in the treatment of this virus, placing emphasis on the scenario of safety through maintenance of therapy with biologic agents, especially when there are no signs or symptoms related to the infection or contact with an infected patient. |
id |
RCAP_c05a6332ec1dfdda0a8bf0e6e8bbaf62 |
---|---|
oai_identifier_str |
oai:repositorio.chporto.pt:10400.16/2586 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Psoriasis, biologic therapy, and the pandemic of the 21st centuryCOVID-19SARS-CoV-2biologiccoronavirus; psoriasisThe pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood. The impact of COVID-19 on patients with psoriasis under biologic agents is continuously being observed in this rapidly changing pandemic. A case-by-case evaluation must be made by dermatologists, and the final decision should be discussed and decided by both the patient and the specialist. Observations reveal that immunosuppressive therapy may have a role in the treatment of this virus, placing emphasis on the scenario of safety through maintenance of therapy with biologic agents, especially when there are no signs or symptoms related to the infection or contact with an infected patient.Bioexcel PublishingRepositório Científico do Centro Hospitalar Universitário de Santo AntónioNogueira, MiguelVender, RonTorres, Tiago2021-11-22T11:57:12Z2020-05-142020-05-14T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/2586engNogueira M, Vender R, Torres T. Psoriasis, biologic therapy, and the pandemic of the 21st century. Drugs Context. 2020;9:2020-4-10. doi:10.7573/dic.2020-4-101745-198110.7573/dic.2020-4-10info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-20T11:01:11Zoai:repositorio.chporto.pt:10400.16/2586Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:38:47.115066Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
title |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
spellingShingle |
Psoriasis, biologic therapy, and the pandemic of the 21st century Nogueira, Miguel COVID-19 SARS-CoV-2 biologic coronavirus; psoriasis |
title_short |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
title_full |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
title_fullStr |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
title_full_unstemmed |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
title_sort |
Psoriasis, biologic therapy, and the pandemic of the 21st century |
author |
Nogueira, Miguel |
author_facet |
Nogueira, Miguel Vender, Ron Torres, Tiago |
author_role |
author |
author2 |
Vender, Ron Torres, Tiago |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Centro Hospitalar Universitário de Santo António |
dc.contributor.author.fl_str_mv |
Nogueira, Miguel Vender, Ron Torres, Tiago |
dc.subject.por.fl_str_mv |
COVID-19 SARS-CoV-2 biologic coronavirus; psoriasis |
topic |
COVID-19 SARS-CoV-2 biologic coronavirus; psoriasis |
description |
The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood. The impact of COVID-19 on patients with psoriasis under biologic agents is continuously being observed in this rapidly changing pandemic. A case-by-case evaluation must be made by dermatologists, and the final decision should be discussed and decided by both the patient and the specialist. Observations reveal that immunosuppressive therapy may have a role in the treatment of this virus, placing emphasis on the scenario of safety through maintenance of therapy with biologic agents, especially when there are no signs or symptoms related to the infection or contact with an infected patient. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-05-14 2020-05-14T00:00:00Z 2021-11-22T11:57:12Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.16/2586 |
url |
http://hdl.handle.net/10400.16/2586 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Nogueira M, Vender R, Torres T. Psoriasis, biologic therapy, and the pandemic of the 21st century. Drugs Context. 2020;9:2020-4-10. doi:10.7573/dic.2020-4-10 1745-1981 10.7573/dic.2020-4-10 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Bioexcel Publishing |
publisher.none.fl_str_mv |
Bioexcel Publishing |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799133648415358976 |